BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 15721240)

  • 1. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.
    Mayer ML
    Neuron; 2005 Feb; 45(4):539-52. PubMed ID: 15721240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.
    Naur P; Vestergaard B; Skov LK; Egebjerg J; Gajhede M; Kastrup JS
    FEBS Lett; 2005 Feb; 579(5):1154-60. PubMed ID: 15710405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors.
    Zhou LM; Gu ZQ; Costa AM; Yamada KA; Mansson PE; Giordano T; Skolnick P; Jones KA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):422-7. PubMed ID: 8996224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY339434, a GluR5 kainate receptor agonist.
    Small B; Thomas J; Kemp M; Hoo K; Ballyk B; Deverill M; Ogden AM; Rubio A; Pedregal C; Bleakman D
    Neuropharmacology; 1998; 37(10-11):1261-7. PubMed ID: 9849663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
    Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
    J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors.
    Donevan SD; Beg A; Gunther JM; Twyman RE
    J Pharmacol Exp Ther; 1998 May; 285(2):539-45. PubMed ID: 9580595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate.
    Jones KA; Wilding TJ; Huettner JE; Costa AM
    Neuropharmacology; 1997 Jun; 36(6):853-63. PubMed ID: 9225313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
    Mayer ML; Ghosal A; Dolman NP; Jane DE
    J Neurosci; 2006 Mar; 26(11):2852-61. PubMed ID: 16540562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA editing of glutamate receptor subunits GluR2, GluR5 and GluR6 in transient cerebral ischemia in the rat.
    Paschen W; Schmitt J; Uto A
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):548-56. PubMed ID: 8964793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro.
    Alt A; Weiss B; Ogden AM; Knauss JL; Oler J; Ho K; Large TH; Bleakman D
    Neuropharmacology; 2004 May; 46(6):793-806. PubMed ID: 15033339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-mode docking search in iGluR homology models implicates three residues in the control of ligand selectivity.
    Rodriguez J; Carcache L; Rein KS
    J Mol Recognit; 2005; 18(2):183-9. PubMed ID: 15476293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
    Valentine ER; Palmer AG
    Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effects of kainate ligands on HEK cell lines expressing recombinant kainate receptors.
    Carver JM; Mansson PE; Cortes-Burgos L; Shu J; Zhou LM; Howe JR; Giordano T
    Brain Res; 1996 May; 720(1-2):69-74. PubMed ID: 8782898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GluR5 and GluR6 kainate receptor subunits coexist in hippocampal neurons and coassemble to form functional receptors.
    Paternain AV; Herrera MT; Nieto MA; Lerma J
    J Neurosci; 2000 Jan; 20(1):196-205. PubMed ID: 10627597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6, and GluR7.
    Cui C; Mayer ML
    J Neurosci; 1999 Oct; 19(19):8281-91. PubMed ID: 10493729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of a glutamate-receptor ligand-binding core in complex with kainate.
    Armstrong N; Sun Y; Chen GQ; Gouaux E
    Nature; 1998 Oct; 395(6705):913-7. PubMed ID: 9804426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
    Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
    Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA.
    Egebjerg J; Bettler B; Hermans-Borgmeyer I; Heinemann S
    Nature; 1991 Jun; 351(6329):745-8. PubMed ID: 1648177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype selectivity and flexibility of ionotropic glutamate receptors upon antagonist ligand binding.
    Pentikäinen U; Settimo L; Johnson MS; Pentikäinen OT
    Org Biomol Chem; 2006 Mar; 4(6):1058-70. PubMed ID: 16525550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Block of kainate receptor desensitization uncovers a key trafficking checkpoint.
    Priel A; Selak S; Lerma J; Stern-Bach Y
    Neuron; 2006 Dec; 52(6):1037-46. PubMed ID: 17178406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.